期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

不同危险组急性早幼粒细胞白血病患者纤溶活性测定的意义 被引量：1

暂未订购
导出
摘要 目的探讨急性早幼粒细胞白血病(APL)治疗过程中纤溶测定的意义。方法通过血浆纤维蛋白原(FIB)和D-二聚体测定检测60例不同危险组APL患者的纤溶活性。结果 APL患者起病时均存在不同程度的纤溶亢进情况,不同危险组患者差异无统计学意义(>0.05)。随着疾病的缓解,纤溶亢进的情况得以纠正,但中高危组较低危组更易发生弥漫性血管内凝血,发生早期死亡。结论治疗期间监测凝血与纤溶指标,对指导临床治疗,降低疾病早期病死率,提高治疗缓解率有重要意义。
作者 邵燕萍 张丽 陈峰 冯长伟 沈健 罗文达
机构地区 台州医院
出处 《现代实用医学》 2012年第1期81-82,共2页 Modern Practical Medicine
关键词 白血病 早幼粒细胞 急性 纤维蛋白原 D-二聚体
分类号 R733.7 [医药卫生—肿瘤]
  • 相关文献

参考文献6

二级参考文献18

  • 1Hair GA, Padula S, Zeff R, et al. Tissue factor expression in human leukemic cells. Leukemia Res, 1996, 20(1):1-11.
  • 2McWilliam N, Robbie L, Booth N, et al. Plasminogen activator in acute myeloid leukemic marrows: u-PA in contrast to t-PA in normal marrow. Br Haemat, 1998,101(4):626-631.
  • 3Scherrer A, Wohlwend A, Kruithof EK, et al. Plasminogen activation in human acute leukemia. Br Haemat,1999,105(4):920-927.
  • 4Aref S, E1-Sherbiny M, Mabed M, et al. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients:a possible relation to disease invasion.Hematology, 2003,8 (6) : 385-391.
  • 5Choi KS, Fitzpatrick SL, Filipenko NR, et al. Regulation of plasmin dependent fibrin clot lysis by annexin Ⅱ heterotetramer. J Biol Chem,2001, 276(27) :25212-25221.
  • 6Menell JS, Cesarman GM, Jacovina AT, et al. AnnexinII and bleeding in acute promyelocytic leukemia. N Engl J Med, 1999,340(13):994-1004.
  • 7Zhang X, Zhou H, Wang J, et al. Arsenic trioxide, retinoic acid and Ara-c regulation the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator. Thromb Res,2002,106(1):63-70.
  • 8Olwill SA, McGlynn H, Gilmore WS, et al. AnnexinII cell surface and mRNA expression in human acute myeloid leukemia cell lines. Thromb Res, 2005,115(1-2):109-114.
  • 9Hryszko T, Malyszko J, Brzosko S, et al. TAFI-thrombin activated fibrinolysis inhibitor. Przeglad Lekarski, 2001, 58 (3):136-138.
  • 10Meijers JC, Oudijk EJ, Mosnier LO, et al. Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor ) in acute promyelocytic leukaemia. Br Haemat, 2000,108(3):518-523.

共引文献45

同被引文献24

  • 1苏雁华,王兆钺.急性早幼粒细胞白血病弥散性血管内凝血发病机制及治疗进展[J].国外医学（输血及血液学分册）,2005,28(6):508-510. 被引量：11
  • 2周静,向兵,贾永前,徐才刚,朱焕玲,崔旭,李建军,刘霆.抗凝血酶Ⅲ和活化蛋白C在急性早幼粒细胞白血病患者出血状态判断中的作用[J].中华检验医学杂志,2006,29(5):466-467. 被引量：1
  • 3BeutlerKL,PrchalKS.威廉姆斯血液学[M].陈竺,陈赛娟,译.北京:人民卫生出版社.2011.
  • 4Tempelhof MW, Benzuly KH, Fintel D, et al. Eptifibatide-induced throm-bocytopenia:with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percuta neous coronary an- gioplastyEptifibatide-induced thrombocytopenia with thrombosis and dis- seminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty [J]. Tex Heart Inst J,2012,39 (1):86-91.
  • 5van Gils JM ,Zwaginga JJ ,Hordijk PL. Molecular and functional interac- tions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases[J]. J Leukoc Biol, 2009,85 (2) :195-204.
  • 6Levi M. Disseminated intravascular coagulation[J]. Crit Care Medicine, 2007,35 (9) :2191-2195.
  • 7Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign :in- ternational guidelines for management of severe sepsis and septic shock, 2012[J]. Intensive Care Med, 2013,39 (2) : 165-228.
  • 8Su YC, Dunn P, Shih LY, et al. Retinoic acid syndrome in patients fol- lowing the treatment of acute promyelocytic leukemia with alhrans retinoic acid[J]. Chang Gung Med J, 2009,32 (5) :535-542.
  • 9Chang H ,Kuo MC ,Shih LY ,et al. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia[J]. Eur J Haematol, 2012,88(4) :321-328.
  • 10Falanga A, Rickles FR. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia[J]. Best Pract Res Clin Hae- matol, 2003,16 (3) : 463-482.

引证文献1

二级引证文献11

现代实用医学
2012年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部